|
LARP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.404400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.275200E-03 |
| Normal-vs-Stage2 |
2.350400E-01 |
| Normal-vs-Stage3 |
5.297000E-01 |
| Normal-vs-Stage4 |
4.872800E-01 |
| Stage1-vs-Stage2 |
3.862200E-01 |
| Stage1-vs-Stage3 |
3.319900E-02 |
| Stage1-vs-Stage4 |
6.488000E-02 |
| Stage2-vs-Stage3 |
5.078800E-01 |
| Stage2-vs-Stage4 |
5.368000E-01 |
| Stage3-vs-Stage4 |
9.437400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.223800E-02 |
| Normal-vs-AfricanAmerican |
9.622000E-01 |
| Normal-vs-Asian |
1.140550E-01 |
| Caucasian-vs-AfricanAmerican |
1.127590E-01 |
| Caucasian-vs-Asian |
6.065700E-02 |
| AfricanAmerican-vs-Asian |
1.160650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.400180E-01 |
| Normal-vs-Female |
2.297800E-03 |
| Male-vs-Female |
4.516200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.698000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.192060E-02 |
| Normal-vs-Age(61-80Yrs) |
9.398400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.605000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.408600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.105200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.694400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.286600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.613600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.225200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.278400E-02 |
| Normal-vs-Grade 2 |
1.655930E-02 |
| Normal-vs-Grade 3 |
6.274000E-02 |
| Normal-vs-Grade 4 |
5.766600E-01 |
| Grade 1-vs-Grade 2 |
1.911960E-01 |
| Grade 1-vs-Grade 3 |
1.518980E-01 |
| Grade 1-vs-Grade 4 |
4.353700E-02 |
| Grade 2-vs-Grade 3 |
6.108600E-01 |
| Grade 2-vs-Grade 4 |
1.633370E-01 |
| Grade 3-vs-Grade 4 |
3.315800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.34909999999411E-06 |
| Normal-vs-ccB subtype |
6.808600E-01 |
| ccA subtype-vs-ccB subtype |
1.72907000000055E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.764000E-02 |
| Normal-vs-N1 |
3.251800E-01 |
| N0-vs-N1 |
7.746400E-01 |
|
|
